Cryofiltration and oral corticosteroids provide successful treatment for an elderly patient with cryoglobulinemic glomerulonephritis associated with hepatitis C virus infection

Internal Medicine

Volumn 39, Issue 7, 2000, Pages 564-569

  Mori, Yasukiyo ^a   Kishimoto, Noriko ^a   Imai, Yoshihito ^a   Tanaka, Yoko ^a   Fujiyama, Atsuko ^a   Shibasaki, Yasunobu ^a   Nagata, Toshiko ^a   Masaki, Hiroya ^a   Umeda, Yukihisa ^a   Matsubara, Hiroaki ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Membranoproliferative glomerulonephritis; Plasma apheresis; Therapy

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; VIRUS ANTIBODY;

AGED; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DRUG SAFETY; GERIATRIC PATIENT; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; MALE; NEPHROTIC SYNDROME; PROTEINURIA; TREATMENT OUTCOME;

EID: 0033941955     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.564     Document Type: Article

References (19)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligman M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775-788, 1974.
2. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162: 569-567, 1990 (letter).
3. Abel G, Zhang Q-X, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36: 1341-1349, 1993.
4. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96: 124-132, 1994.
5. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumtol 9: 621-624, 1991.
6. Yamabe H, Johnson RJ, Gretch DR, et al. Hepatitis C virus Infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6: 220-223, 1995.
7. Monti G, Galli M, Invernizzi F, et al, and Italian Group for the Study of Cryoglobulinemias. Cryoglobulinemias: A Multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. QJM 88: 115-126, 1995.
8. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54: 650-671, 1998 (clinical conference).
9. Cattran DC. Interferon therapy: a double-edged sword? Am J Kidney Dis 33: 1174-1176, 1999 (editorial; comment).
10. Siami FS, Siami GA. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Therapeutic Apheresis 1: 58-62, 1997.
11. Fornasieri A, Armelloni S, Bernasconi P, et al. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immunecomplex glomerulonephritis. Am J Kidney Dis 27: 476-483, 1996.
12. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7: 367-386, 1996 (editorial).
13. Ohshima T, Sawada K, Tanaka J, Zborowski M, Koo AP, Malchesky PS. Do humoral factors removed by plasmapheresis suppress the cellular immune system in cryoglobulinemia? ASAIO Trans 37: M431-M433, 1991.
14. Treichel U, Wandel E, Gerken G, Dienes HP, Meyer zum Buschenfelde KH. HCV-associated cryoglobulinaemia presenting with vasculitis, hepatitis, and Glomerulonephritis-a therapeutic dilemma. Nephrol Dial Transplant 11: 1168-1171, 1996.
15. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465-470, 1993.
16. Ohta S, Yokoyama H, Wada T, et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 33: 1040-1048, 1999.
17. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 127: 875-881, 1997.
18. Bennett WG, Inoue Y, Neck JR, Wong JB, Pauker SG. Estimates of the cost-effectiveness of a single course of interferon-alpha therapy 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 127: 855-865, 1997.
19. Colucci G, Gutekunst K. Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C. J Viral Hepat 4 (Suppl 1): 75-78, 1997.